0001209191-18-047813.txt : 20180821
0001209191-18-047813.hdr.sgml : 20180821
20180821175612
ACCESSION NUMBER: 0001209191-18-047813
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170613
FILED AS OF DATE: 20180821
DATE AS OF CHANGE: 20180821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zuo William Wei
CENTRAL INDEX KEY: 0001427110
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 181031078
MAIL ADDRESS:
STREET 1: 3040 POST OAK BLVD
STREET 2: SUITE 1110
CITY: HOUSTON
STATE: TX
ZIP: 77056
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2017-06-13
2017-06-21
0
0001300699
Athenex, Inc.
ATNX
0001427110
Zuo William Wei
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
0
1
0
0
President, China Division
Stock Option (Right to Buy)
11.00
2017-06-13
4
A
0
1
0.00
A
2018-06-13
2027-06-13
Common Stock
1
1
D
This option was previously reported by Dr. Zuo. This amendment is being filed to correct the transaction date, exercise date, and expiration date.
/s/ Teresa Bair, Attorney-in-Fact
2018-08-21